Combinatorial treatment of Rhizoma Paridis saponins and sorafenib overcomes the intolerance of sorafenib-Reference-Cited by-同舟云学术

Combinatorial treatment of Rhizoma Paridis saponins and sorafenib overcomes the intolerance of sorafenib

Published:2018-10 Issue: Volume:183 Page:159-166
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Yao Jingwen,Man Shuli,Dong Honghong,Yang Li,Ma Long,Gao Wenyuan

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference22 articles.

1. Cancer statistics for Asian Americans, native Hawaiians, and Pacific Islanders, 2016: converging incidence in males and females;Torre;CA: Cancer J. Clin.,2016

2. Molecular targeted therapies in hepatocellular carcinoma;Llovet;Hepatology,2008

3. Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature;Abdel-Rahman;Crit. Rev. Oncol. Hematol.,2014

4. Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma;Shen;Br. J. Cancer,2013

5. Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth;van Malenstein;Cancer Lett.,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and biological evaluation of panaxadiol ester derivatives possessing pyrazole and pyrrole moiety as HIF-1α inibitors;Fitoterapia;2024-09

2. Chitosan nanoparticles, camel milk exosomes and/or Sorafenib induce apoptosis, inhibit tumor cells migration and angiogenesis and ameliorate the associated liver damage in Ehrlich ascites carcinoma-bearing mice;Beni-Suef University Journal of Basic and Applied Sciences;2024-08-02

3. Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8+ effector T cells in hepatocellular carcinoma;Biochemical Pharmacology;2024-07

4. Natural products target glycolysis in liver disease;Frontiers in Pharmacology;2023-08-17

5. Dehydroevodiamine Targeting ACHE and ALDH3A1 Regulate Glycolytic Metabolism to Inhibit Hepatocellular Carcinoma Cell Apoptosis;Natural Product Communications;2023-08